EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor

CHEBI:CHEBI_38317

Definition

An EC 1.13.11.* (oxidoreductase acting on single donors and incorporating 2 atoms of oxygen) inhibitor that interferes with the activity of 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27).

Alternative Names

  • 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) inhibitor
  • 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) inhibitors
  • 4-hydroxyphenylpyruvate dioxygenase inhibitor
  • 4-hydroxyphenylpyruvate dioxygenase inhibitors
  • 4-hydroxyphenylpyruvate hydroxylase inhibitor
  • 4-hydroxyphenylpyruvate hydroxylase inhibitors
  • 4-hydroxyphenylpyruvate:oxygen oxidoreductase (hydroxylating, decarboxylating) inhibitor
  • 4-hydroxyphenylpyruvate:oxygen oxidoreductase (hydroxylating, decarboxylating) inhibitors
  • 4-hydroxyphenylpyruvic acid dioxygenase inhibitor
  • 4-hydroxyphenylpyruvic acid dioxygenase inhibitors
  • EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitors
  • EC 1.13.11.27 inhibitor
  • EC 1.13.11.27 inhibitors
  • HPPD inhibitor
  • HPPD inhibitors
  • p-hydroxyphenylpyruvate dioxygenase inhibitor
  • p-hydroxyphenylpyruvate dioxygenase inhibitors
  • p-hydroxyphenylpyruvate hydroxylase inhibitor
  • p-hydroxyphenylpyruvate hydroxylase inhibitors
  • p-hydroxyphenylpyruvate oxidase inhibitor
  • p-hydroxyphenylpyruvate oxidase inhibitors
  • p-hydroxyphenylpyruvic acid hydroxylase inhibitor
  • p-hydroxyphenylpyruvic acid hydroxylase inhibitors
  • p-hydroxyphenylpyruvic hydroxylase inhibitor
  • p-hydroxyphenylpyruvic hydroxylase inhibitors
  • p-hydroxyphenylpyruvic oxidase inhibitor
  • p-hydroxyphenylpyruvic oxidase inhibitors

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:38317

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#id
CHEBI:38317
core#notation
CHEBI:38317
oboInOwl#hasAlternativeId
CHEBI:50380
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_38321
owl#someValuesFrom
t210162
owl#annotatedSource
t211073